Beth Weinman to Present at Pharmaceutical and Medical Device Ethics and Compliance Congress

Practices: FDA Regulatory, Health Care, Technology, Media & Telecommunications, Digital Health, Biomedical Research: Human, Animal and Bench Science

Life sciences regulatory & compliance counsel Beth Weinman will present on “New and Emerging Risks for Medical Devices” at the 23rd Pharmaceutical and Medical Device Ethics and Compliance Congress in Washington, D.C. on October 24.

Beth will be joined on the panel by Melissa Fitzgerald, Olympus Corporation of America Privacy Officer; Katherine Norris, Epsilon Life Sciences Managing Director and Sujata Dayal, Medline Industries Vice President and Global Chief Compliance Officer.

Cookie Settings